Eloxx Pharmacueticals Receives A US$5 Million Investment from Quark Venture and GF Securities to Advance A Novel Disease-Modifying ...
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jun 8, 2017) - Today, Quark Venture Inc. and GF Securities announced a $US5 million investment Eloxx Pharmaceuticals through their Global Health Science Fund. This investment is part of a US$24 million financing …